Cephalon To Pay $1.2B To End FTC Pay-For-Delay Suit
Cephalon Inc. agreed Thursday to pay $1.2 billion to settle a long-running antitrust suit accusing the company of paying generic-drug makers to hold off on launching their own version of narcolepsy...To view the full article, register now.
Already a subscriber? Click here to view full article